Does your research have commercial potential?

You didn’t go into science to build a company—you did it to solve real problems. To push the boundaries of what we know about disease. To help patients who’ve run out of options. But what if the most effective way to turn your discovery into a treatment wasn’t another grant or publication—but a startup? For researchers with a genuine desire to make a difference, launching a company isn’t only about chasing profits — it’s about translating years of work into real-world outcomes. It’s about making sure your science gets to the people who need it most.

If you're a scientist sitting on promising preclinical data and you want to use that data to actually help people in need, you are probably wondering how to take the leap into entrepreneurship.

How do you know if your academic research can become the foundation of a biotech startup?

The truth is, not all science makes for a good company. But some of it does—and chances are, if you're asking the question, you're already further along than most. These are the questions you need to answer when evaluating whether your research can become a biotech startup.

Does your research solve a real, unmet problem?

Is there a clear path to translation?

Can it be protected?

Is there a market for it?

Are you willing to be a founder (or partner with one)?

The Synaptic Gap can help researchers answer these questions and those that follow to assist potential founders in building a company. We help researchers reframe their story, sharpen their development strategy, and build compelling and fundable proposals that meet the expectations of both scientific and commercial stakeholders.